Literature DB >> 20020295

Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients.

Corrado Pedrazzani1, Armands Sivins, Guntis Ancans, Daniele Marrelli, Giovanni Corso, Viesturs Krumins, Franco Roviello, Marcis Leja.   

Abstract

BACKGROUND: The aim of this study was to evaluate the prognostic value of the ratio of metastatic to examined lymph nodes (N ratio) in gastric cancer patients who underwent limited lymphadenectomy and had a small number (< or =15) of analyzed nodes.
METHODS: The prognostic value of the actual AJCC/UICC pN staging system and the N ratio (0%, 1-25%, > 25%) were analyzed by means of univariate and multivariate analyses for 526 patients who underwent R0 resection for gastric adenocarcinoma at the Latvia Oncology Center.
RESULTS: The mean (SD) number of analyzed nodes was 5.6 (2.8). The number of positive nodes significantly increased with the number of analyzed nodes (p < 0.001). No significant differences in survival (p = 0.508) and risk of death (p = 0.224) were observed between pN1 and pN2 subsets. When the N ratio (1-25% vs. > 25%) was taken into account, a significant difference was demonstrated between pNR1 and pNR2 with respect to survival (p = 0.017) and risk of death (p = 0.012). Nonetheless, the joint allocation of the two classifications demonstrated that only a minority of patients (28 cases) belonged to the pNR1 subset and none of these belonged to the AJCC/UICC pN2 subset.
CONCLUSIONS: When a small number of lymph nodes are analyzed, the N ratio can discriminate patients better than TNM classification. However, because a small number of retrieved nodes produced only a small number of pNR1 patients, the N ratio classification cannot be justified for clinical use.

Entities:  

Mesh:

Year:  2010        PMID: 20020295     DOI: 10.1007/s00268-009-0288-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  Prognostic impact of positive lymph node ratio in gastric carcinoma.

Authors:  Orhan Celen; Emin Yildirim; Uğur Berberoglu
Journal:  J Surg Oncol       Date:  2007-08-01       Impact factor: 3.454

2.  Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer.

Authors:  R Persiani; S Rausei; A Biondi; S Boccia; F Cananzi; D D'Ugo
Journal:  Eur J Surg Oncol       Date:  2007-07-10       Impact factor: 4.424

3.  Surgical treatment of gastric cancer in Latvia: results of centralized experience.

Authors:  A Sivins; C Pedrazzani; F Roviello; G Ancans; M Timofejevs; A Pcholkins; V Krumins; V Boka; A Stengrevics; M Leja
Journal:  Eur J Surg Oncol       Date:  2008-12-30       Impact factor: 4.424

4.  Nodal staging in adenocarcinoma of the gastro-esophageal junction. Proposal of a specific staging system.

Authors:  Corrado Pedrazzani; Giovanni deManzoni; Daniele Marrelli; Simone Giacopuzzi; Giovanni Corso; Marco Bernini; Franco Roviello
Journal:  Ann Surg Oncol       Date:  2006-12-05       Impact factor: 5.344

5.  Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system.

Authors:  K Fujii; H Isozaki; K Okajima; E Nomura; M Niki; S Sako; N Izumi; H Mabuchi; K Nishiguchi; N Tanigawa
Journal:  Br J Surg       Date:  1999-05       Impact factor: 6.939

6.  Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma.

Authors:  H Katai; K Yoshimura; K Maruyama; M Sasako; T Sano
Journal:  Cancer       Date:  2000-04-15       Impact factor: 6.860

7.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Authors:  A R Feinstein; D M Sosin; C K Wells
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

8.  The impact of total retrieved lymph nodes on staging and survival of patients with pT3 gastric cancer.

Authors:  Jia Yun Shen; Sungsoo Kim; Jae-Ho Cheong; Yong Il Kim; Woo Jin Hyung; Won Hyuk Choi; Seung Ho Choi; Lin Bo Wang; Sung Hoon Noh
Journal:  Cancer       Date:  2007-08-15       Impact factor: 6.860

9.  Appraisal of compliance with the UICC/AJCC staging system in the staging of gastric cancer. Union Internacional Contra la Cancrum/American Joint Committee on Cancer.

Authors:  P J Mullaney; M S Wadley; C Hyde; J Wyatt; G Lawrence; M T Hallissey; J W L Fielding
Journal:  Br J Surg       Date:  2002-11       Impact factor: 6.939

10.  The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients.

Authors:  Alberto Marchet; Simone Mocellin; Alessandro Ambrosi; Paolo Morgagni; Domenico Garcea; Daniele Marrelli; Franco Roviello; Giovanni de Manzoni; Annamaria Minicozzi; Giovanni Natalini; Francesco De Santis; Luca Baiocchi; Arianna Coniglio; Donato Nitti
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

View more
  10 in total

1.  Limited lymph node dissection and metastatic lymph node ratio: a wave of trust.

Authors:  Alberto Biondi; Roberto Persiani; Ferdinando Cananzi; Marco Zoccali; Andrea Tufo; Domenico D'Ugo
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

2.  Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer?

Authors:  Ibrahim Sakcak; Barış Doğu Yıldız; Fatih Mehmet Avşar; Saadet Akturan; Kemal Kilic; Erdal Cosgun; Enver O Hamamci
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

3.  The evaluation of metastatic lymph node ratio staging system in gastric cancer.

Authors:  Yanbing Zhou; Jizhun Zhang; Shougen Cao; Yu Li
Journal:  Gastric Cancer       Date:  2012-09-04       Impact factor: 7.370

Review 4.  Digestive cancer surgery in the era of sentinel node and epithelial-mesenchymal transition.

Authors:  Nadia Peparini
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

5.  A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes.

Authors:  Sharvesh Raj Seeruttun; Lipu Xu; Fangwei Wang; Xiaodong Yi; Cheng Fang; Zhimin Liu; Wei Wang; Zhiwei Zhou
Journal:  Cancer Commun (Lond)       Date:  2019-06-10

6.  The Prognostic Value of Lymph Node Ratio after Neoadjuvant Chemotherapy in Patients with Locally Advanced Gastric Adenocarcinoma.

Authors:  Kankai Zhu; Hailong Jin; Zhijian Li; Yuan Gao; Qing Zhang; Xiaosun Liu; Jiren Yu
Journal:  J Gastric Cancer       Date:  2021-03-24       Impact factor: 3.720

7.  Prognostic value of the lymph node ratio in stage III gastric cancer patients undergoing radical resection.

Authors:  Bin Ke; Xi-Na Song; Ning Liu; Ru-Peng Zhang; Chang-Li Wang; Han Liang
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

Review 8.  Alternative staging of regional lymph nodes in gastric cancer.

Authors:  Antoni M Szczepanik; Agata Paszko; Miroslaw Szura; Thecla Scully-Horner; Jan Kulig
Journal:  Prz Gastroenterol       Date:  2016-07-27

9.  Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection.

Authors:  Hongdian Zhang; Xiaobin Shang; Chuangui Chen; Yongyin Gao; Xiangming Xiao; Peng Tang; Xiaofeng Duan; Mingjian Yang; Hongjing Jiang; Zhentao Yu
Journal:  Oncotarget       Date:  2016-11-08

10.  Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer.

Authors:  Yi Hou; Xudong Wang; Jing Chen
Journal:  World J Surg Oncol       Date:  2018-10-04       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.